Fatty Acid Synthase and Its Inhibitors in Endometrial Cancer
FENG Ya-ru
LI Xue
ZHANG Hui-ying
Abstract：Fatty acid synthase(FASN)is a key enzyme in the fatty acid synthesis that catalyzes the de novo synthesis of lipids.Most of the fatty acids are of food origin in normal tissues,while fatty acids are dependent on the de novo synthesis of lipids in endometrial cancer cells.Previous studies have shown that FASN expression is associated with the development,progression and poor prognosis of endometrial malignancies.The overexpression of FASN is correlated with mitogen extracellular kinase(MEK)/extracellular signal-regulated kinase(ERK)/mitogen-activated protein kinase(MAPK)and phosphoinositide 3-kinase(PI3K)/protein kinase B(Akt)/mammalian target of rapamycin(mTOR)signaling pathways.Specific blockade of its activity can significantly inhibit the growth and proliferation of tumor cells.We review the action of FASN and mechanism in endometrial malignancies and the progress of FASN inhibitors such as C75,C93,orlistat and so on,in endometrial cancer or other tumors,with the aim of providing new ideas for the treatment of endometrial tumors.
Keywords：Fatty acid synthasesEnzyme inhibitorsTherapyPrognosisEndometrial neoplasms
Publication Date：2024-01-15
Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)
Pages：5( 79-82,88 )